BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luk A, Chan JC. Diabetic nephropathy--what are the unmet needs? Diabetes Res Clin Pract 2008;82 Suppl 1:S15-20. [PMID: 18952313 DOI: 10.1016/j.diabres.2008.09.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Fallahzadeh MK, Dormanesh B, Sagheb MM, Roozbeh J, Vessal G, Pakfetrat M, Daneshbod Y, Kamali-sarvestani E, Lankarani KB. Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Kidney Diseases 2012;60:896-903. [DOI: 10.1053/j.ajkd.2012.06.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
2 Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar MW, Shafi T, Thornalley PJ. Thiamine in diabetic nephropathy: a novel treatment modality? Reply to Alkhalaf A, Kleefstra N, Groenier KH et al. [letter]. Diabetologia 2009;52:1214-6. [DOI: 10.1007/s00125-009-1334-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathol 2013;2:20-7. [PMID: 24475422 DOI: 10.5812/nephropathol.9093] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
4 Kaur R, Sodhi RK, Aggarwal N, Kaur J, Jain UK. Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats. Naunyn Schmiedebergs Arch Pharmacol 2016;389:73-85. [PMID: 26475618 DOI: 10.1007/s00210-015-1182-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Fang J, Wei H, Sun Y, Zhang X, Liu W, Chang Q, Wang R, Gong Y. Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule). BMC Complement Altern Med 2013;13:76. [PMID: 23560927 DOI: 10.1186/1472-6882-13-76] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
6 Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64-91. [PMID: 23551121 DOI: 10.1111/nyas.12098] [Cited by in Crossref: 401] [Cited by in F6Publishing: 368] [Article Influence: 44.6] [Reference Citation Analysis]
7 Chan JC. What can we learn from the recent blood glucose lowering megatrials? J Diabetes Investig 2011;2:1-5. [PMID: 24843455 DOI: 10.1111/j.2040-1124.2010.00063.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Louro TM, Matafome PN, Nunes EC, da Cunha FX, Seiça RM. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats. Eur J Pharmacol 2011;653:89-94. [PMID: 21167150 DOI: 10.1016/j.ejphar.2010.11.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
9 Chan JC, So W, Ma RC, Tong PC, Wong R, Yang X. The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry. Curr Cardiovasc Risk Rep 2011;5:230-9. [PMID: 21654912 DOI: 10.1007/s12170-011-0172-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
10 Xiao Y, Liu Y, Yu K, Zhou L, Bi J, Cheng J, Li F, Luo R, Zhao X. The effect of chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2013;2013:937549. [PMID: 24062795 DOI: 10.1155/2013/937549] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
11 Lim LL, Lau ESH, Fung E, Lee HM, Ma RCW, Tam CHT, Wong WKK, Ng ACW, Chow E, Luk AOY, Jenkins A, Chan JCN, Kong APS. Circulating branched-chain amino acids and incident heart failure in type 2 diabetes: The Hong Kong Diabetes Register. Diabetes Metab Res Rev. 2020;36:e3253. [PMID: 31957226 DOI: 10.1002/dmrr.3253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chan JCN, Zhang Y, Ning G. Diabetes in China: a societal solution for a personal challenge. The Lancet Diabetes & Endocrinology 2014;2:969-79. [DOI: 10.1016/s2213-8587(14)70144-5] [Cited by in Crossref: 126] [Cited by in F6Publishing: 63] [Article Influence: 15.8] [Reference Citation Analysis]
13 Luo Y, Yang SK, Zhou X, Wang M, Tang D, Liu FY, Sun L, Xiao L. Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta-analysis. Ren Fail 2015;37:614-34. [PMID: 25682973 DOI: 10.3109/0886022X.2015.1009820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
14 Ma RC. Genetics of cardiovascular and renal complications in diabetes. J Diabetes Investig 2016;7:139-54. [PMID: 27042264 DOI: 10.1111/jdi.12391] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
15 Chen HM, Shen WW, Ge YC, Zhang YD, Xie HL, Liu ZH. The relationship between obesity and diabetic nephropathy in China. BMC Nephrol 2013;14:69. [PMID: 23521842 DOI: 10.1186/1471-2369-14-69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Cc Chow F, Chan SP, Hwu CM, Suwanwalaikorn S, Wu AY, Gan SY, Zacarias MB. Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspective. J Diabetes Investig 2012;3:481-9. [PMID: 24843611 DOI: 10.1111/jdi.12006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
17 Lau TW, Tan KEK, Choo JCJ, Ng TG, Tavintharan S, Chan JCN. Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction. J Diabetes 2018;10:200-12. [PMID: 28960806 DOI: 10.1111/1753-0407.12610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Chan JC, Chan SP, Deerochanawong C, Go RT, Lee K, Ma RC, Pan C, Sheu WH, Barter P. Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don’t know. Diabetes Research and Clinical Practice 2011;94:1-13. [DOI: 10.1016/j.diabres.2011.05.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chuang SM, Lee CC, Lo WY, Hsieh CL. Effect of acupressure at Sanyinjiao on albuminuria in patients with early diabetic nephropathy: A single-blind, randomized, controlled preliminary study. Explore (NY) 2020;16:165-9. [PMID: 31591045 DOI: 10.1016/j.explore.2019.09.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]